U.S. markets close in 6 hours 12 minutes
  • S&P 500

    4,126.68
    -1.31 (-0.03%)
     
  • Dow 30

    33,572.12
    -173.28 (-0.51%)
     
  • Nasdaq

    13,953.85
    +103.85 (+0.75%)
     
  • Russell 2000

    2,237.19
    +3.41 (+0.15%)
     
  • Crude Oil

    60.27
    +0.57 (+0.95%)
     
  • Gold

    1,747.30
    +14.60 (+0.84%)
     
  • Silver

    25.42
    +0.55 (+2.20%)
     
  • EUR/USD

    1.1945
    +0.0027 (+0.23%)
     
  • 10-Yr Bond

    1.6690
    -0.0060 (-0.36%)
     
  • GBP/USD

    1.3743
    +0.0001 (+0.00%)
     
  • USD/JPY

    109.1800
    -0.1960 (-0.18%)
     
  • BTC-USD

    62,772.01
    +2,158.61 (+3.56%)
     
  • CMC Crypto 200

    1,337.10
    +43.11 (+3.33%)
     
  • FTSE 100

    6,879.35
    -9.77 (-0.14%)
     
  • Nikkei 225

    29,751.61
    +212.88 (+0.72%)
     

EU regulator endorses Regeneron antibody cocktail to treat COVID-19

  • Oops!
    Something went wrong.
    Please try again later.

Feb 26 (Reuters) - Europe's medicines regulator said on Friday that an antibody drug combination developed by Regeneron Pharmaceuticals can be used to treat COVID-19 patients who do not require oxygen support and are at high risk of progressing to severe illness.

The recommendation can now be used for guidance in individual European nations on the possible use of the combination of casirivimab and imdevimab before a marketing authorisation is issued, the European Medicines Agency said. (https://bit.ly/3syYgzB) (Reporting by Pushkala Aripaka in Bengaluru; Editing by Shounak Dasgupta)